Morepen Laboratories Limited (MOREPENLAB)
ISIN: - Industry: Drug Manufacturers—Specialty & Generic Sector: Healthcare Website
36.75
-0.05(-0.14%)

Morepen Laboratories Limited develops, manufactures, markets, and sells active pharmaceutical ingredients (APIs), branded and generic formulations, and home health products in India. The company offers APIs for anti-histaminic, anti-asthmatic, anti-hypercholesterolemic, anti-hypertensive, and anti-diabetic drugs; point of care and medical devices; and home diagnostic products, such as air purifiers, thermometers, stethoscopes, blood pressure monitors, pulse-oximeters, nebulizers, glucometers, strips, sanitizers, disinfectant solutions, masks and gloves, and others. It also provides Burnol, a burn cream; Lemolate for cough and cold; and Fiber-X, a sat isabgol; and formulations for gastro, antibiotics, vitamins, nutritional, and anti-diabetics, as well as cardiac. In addition, the company is involved in the product contract manufacturing and brand sharing businesses; and provision of over-the-counter products under the Dr. Morepen brand. It exports its products to approximately 75 countries. Morepen Laboratories Limited was incorporated in 1984 and is based in New Delhi, India.

Pricing Updates

TODAY'S HIGH

37.45

TODAY'S LOW

36.65

52 WEEK HIGH

73.85

52 WEEK LOW

32.3

Major Holders

% of Shares Held by
All Insider

51.19%

% of Shares Held by
Institutions

0.76%

% of Float Held by
Institutions

1.56%

Number of Institutions
Holding Shares

4

Company Overview

MARKET CAP

1834.44 Cr.

ETERPRISE VALUE

1658.59 Cr.

NO. OF SHARES

49.91 Cr.

BOOK VALUE

12.676

DIV. YIELD

0.6%

DEBT

18.56 Cr.

GROSS PROFIT

488.88 Cr.

CASH

45.97 Cr.

REVENUE

1557.13 Cr.

REVENUE/SHARE

34.609

OHLC Chart 1y 2y 5y 10y

Price Chart

1d 1w 1m 3m 6m 1Yr 2Yr 5Yr

Volumes Chart

1d 1w 1m 3m 6m 1Yr 2Yr 5Yr

Cashflows

ParticularsMar 2022Mar 2021Mar 2020Mar 2019
Investments1.54 Cr.1.54 Cr.-1.06 Cr.19.53 Lakhs
Change To Liabilities2.48 Cr.000
Total cashflows from Investing Activities-31.67 Cr.-70.35 Cr.-12.46 Cr.-13.05 Cr.
Net Borrowings1.52 Cr.3.57 Cr.1.52 Cr.-2.62 Cr.
Total Cash from Financing Activities63.85 Cr.47.27 Cr.5.48 Cr.-44.10 Lakhs
Other Liabilities-12.28 Cr.2.96 Cr.-10.63 Cr.-22.58 Cr.
Total Assets0000
Net Income101.68 Cr.97.08 Cr.33.57 Cr.28.84 Cr.
Change in Cash-25.58 Cr.27.74 Cr.4.04 Cr.3.87 Cr.
Effect of Exchange Rate0000
Total Cash from Operating Activities-57.75 Cr.50.82 Cr.11.01 Cr.17.37 Cr.
Depreciation27.64 Cr.24.82 Cr.36.90 Cr.39.89 Cr.
Other Cashflows from Investing Activities33.98 Cr.-29.95 Cr.5.66 Cr.-1.42 Cr.
Dividends Paid0-48.92 Lakhs-48.92 Lakhs-49.63 Lakhs
Change to Inventory-100.52 Cr.-36.85 Cr.-44.27 Cr.-17.31 Cr.
Change to Account Receivables-68.65 Cr.-44.30 Cr.-3.93 Cr.-11.89 Cr.
Other Cashflows from Financing Activities62.32 Cr.44.18 Cr.4.45 Cr.2.67 Cr.
Change to Net Income-8.09 Cr.1.64 Cr.-62.07 Lakhs41.78 Lakhs
Capital Expenditures-45.44 Cr.-21.79 Cr.-16.66 Cr.-8.50 Cr.

Financials

ParticularsMar 2022Mar 2021Mar 2020Mar 2019
Research DevelopmentNoneNoneNoneNone
Effect of Accounting ChargesNoneNoneNoneNone
Income Before Tax126.70 Cr.98.51 Cr.39.10 Cr.29.17 Cr.
Minority Interest-46.07 Lakhs-45.93 Lakhs-46.34 Lakhs-46.31 Lakhs
Net Income119.33 Cr.98.16 Cr.36.90 Cr.30.47 Cr.
Selling General Administrative263.45 Cr.135.59 Cr.114.25 Cr.99.53 Cr.
Gross Profit488.88 Cr.417.44 Cr.294.92 Cr.267.77 Cr.
Ebit119.33 Cr.98.16 Cr.36.90 Cr.30.47 Cr.
Operating Income119.33 Cr.98.16 Cr.36.90 Cr.30.47 Cr.
Other Operating Expenses78.44 Cr.153.40 Cr.106.85 Cr.97.87 Cr.
Interest Expense0-1.78 Cr.-1.98 Cr.-2.11 Cr.
Extraordinary ItemsNoneNoneNoneNone
Non RecurringNoneNoneNoneNone
Other ItemsNoneNoneNoneNone
Income Tax Expense25.02 Cr.1.42 Cr.5.52 Cr.33.63 Lakhs
Total Revenue1557.13 Cr.1197.99 Cr.858.35 Cr.771.38 Cr.
Total Operating Expenses1437.79 Cr.1099.82 Cr.821.45 Cr.740.91 Cr.
Cost of Revenue1068.24 Cr.780.54 Cr.563.43 Cr.503.60 Cr.
Total Other Income Expense Net7.36 Cr.34.61 Lakhs2.20 Cr.-1.29 Cr.
Discontinued OperationsNoneNoneNoneNone
Net Income from Continuous Ops.101.68 Cr.97.09 Cr.33.57 Cr.28.84 Cr.
Net Income Applicable to Common Shares101.68 Cr.97.08 Cr.33.57 Cr.28.84 Cr.

Balance Sheet

ParticularsMar 2022Mar 2021Mar 2020Mar 2019
Intangible Assets30.67 Cr.20.76 Cr.7.80 Cr.14.36 Cr.
Capital Surplus0167.40 Cr.167.40 Cr.167.40 Cr.
Total Liabilities491.95 Cr.433.85 Cr.379.86 Cr.362.54 Cr.
Stock Holder Equity578.56 Cr.424.74 Cr.284.06 Cr.253.09 Cr.
Minority Interest-46.07 Lakhs-45.93 Lakhs-46.34 Lakhs-46.31 Lakhs
Other Liabilities181.09 Cr.38.85 Cr.31.41 Cr.26.16 Cr.
Total Assets1070.05 Cr.858.14 Cr.663.46 Cr.615.17 Cr.
Common Stock95.55 Cr.89.95 Cr.89.95 Cr.89.95 Cr.
Retained Earnings054.65 Cr.-42.43 Cr.-76.01 Cr.
Other Liabilities34.17 Cr.29.22 Cr.27.49 Cr.21.54 Cr.
Good Will74.47 Cr.74.47 Cr.74.47 Cr.74.47 Cr.
Treasury Stock483 Cr.112.73 Cr.69.12 Cr.71.74 Cr.
Other Assets69.80 Cr.103.78 Cr.73.83 Cr.79.49 Cr.
Cash45.97 Cr.41.38 Cr.13.63 Cr.9.59 Cr.
Current Liabilities456.45 Cr.403.80 Cr.351.44 Cr.339.16 Cr.
Long Term Asset Charges0000
Short Long Term Debt17.24 Cr.120.54 Cr.120.83 Cr.120.77 Cr.
Other Stockholder Equity483 Cr.112.73 Cr.69.12 Cr.71.74 Cr.
Property Plant Equipment160.79 Cr.131.24 Cr.134.08 Cr.147.36 Cr.
Total Cur. Assets734.30 Cr.526.79 Cr.372.17 Cr.299.46 Cr.
Long Term Investments01.08 Cr.1.08 Cr.0
Net Tangible Assets473.41 Cr.329.51 Cr.201.77 Cr.164.25 Cr.
Short Term Investments0002.25 Lakhs
Net Receivables256.04 Cr.191.08 Cr.142.60 Cr.141.08 Cr.
Long Term Debt1.32 Cr.82.83 Lakhs92.46 Lakhs1.82 Cr.
Inventory275.85 Cr.175.32 Cr.138.47 Cr.94.20 Cr.
Accounts Payable258.11 Cr.208.84 Cr.172.30 Cr.168.15 Cr.

New Offers


Upstox offer
Upstox

Open a demat account through us and get the account opening charges waived off

open paperless account